These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19378345

  • 1. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
    Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF.
    Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
    [Abstract] [Full Text] [Related]

  • 2. Natural history of chronic hepatitis B REVEALed.
    Chen CJ, Yang HI.
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [Abstract] [Full Text] [Related]

  • 3. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T, Shibuya A, Takeuchi A, Shibata Y, Hidaka H, Okuwaki Y, Takada J, Tanaka Y, Watanabe M, Minamino T, Sakurai K, Koizumi W.
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
    Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ, Lai MY, Chen DS, Kao JH.
    Hepatology; 2007 May; 45(5):1193-8. PubMed ID: 17464993
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK.
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [Abstract] [Full Text] [Related]

  • 6. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [Abstract] [Full Text] [Related]

  • 7. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA.
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [Abstract] [Full Text] [Related]

  • 9. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.
    Tai DI, Tsay PK, Chen WT, Chu CM, Liaw YF.
    Am J Gastroenterol; 2010 May; 105(5):1102-9. PubMed ID: 20197760
    [Abstract] [Full Text] [Related]

  • 10. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR, Gani RA, Hasan I, Simadibrata M, Sulaiman AS, Pakasi LS, Budihusodo U, Krisnuhoni E, Lesmana LA.
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [Abstract] [Full Text] [Related]

  • 12. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN, Liaw YF, Atkins M.
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [Abstract] [Full Text] [Related]

  • 13. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
    Liu SQ, Zhu XJ, Sun XH, Li M, Gao YQ.
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
    [Abstract] [Full Text] [Related]

  • 14. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
    Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF.
    J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
    [Abstract] [Full Text] [Related]

  • 15. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ, R.E.V.E.A.L.-HBV Study Group.
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [Abstract] [Full Text] [Related]

  • 16. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J, Lai CL, Young J, Wong DK, Yuen J, Seto WK, Yuen MF.
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [Abstract] [Full Text] [Related]

  • 17. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [Abstract] [Full Text] [Related]

  • 18. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY, Um SH, Jung JY, Seo YS, Yim HJ, Ryu HS, Chun HJ, Jeen YT, Kim CD, Keum B, Lee HS.
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [Abstract] [Full Text] [Related]

  • 19. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [Abstract] [Full Text] [Related]

  • 20. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ.
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.